Hinge Health stock jumps again in premarket as 2026 outlook keeps HNGE in play
Hinge Health shares rose 0.4% to $38.90 in premarket trading Thursday after a 17.3% surge Wednesday, driven by a 2026 revenue forecast of $732 million to $742 million. Fourth-quarter revenue climbed 46% to $170.7 million, with adjusted EPS at $0.49. RBC cut its price target to $50 but maintained an Outperform rating. The company reported a large GAAP operating loss for 2025 despite adjusted profitability.
